DOI: 10.1055/s-00042120

International Journal of Recent Surgical and Medical Sciences

Referenz

Cherian JJ, Parvizi J, Bramlet D, Lee KH, Romness DW, Mont MA.
Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee.

Osteoarthritis Cartilage 2015;
23 (12) 2109-2118

Bibliographische Angaben herunterladen

Aufrufen in: